PAVmed Announces Reverse Stock Split Implementation
PAVmed Inc. (NASDAQ: PAVM), a prominent player in the medical technology sector, has announced a significant corporate action—a 1-for-30 reverse stock split of its common stock, set to take effect soon. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement while enhancing the overall market perception of the company's stock. PAVmed operates extensively in the medical device, diagnostics, and digital health realms, showcasing its commitment to advancing healthcare technology.
Details of the Stock Split
The reverse stock split will officially become effective at 12:01 a.m. Eastern Time on January 2, 2026. After this date, PAVmed's common stock will continue to trade on the Nasdaq under the symbol "PAVM" but on a split-adjusted basis. This decision followed thorough discussions and approvals during the Company's special meeting held earlier. The stockholders consented to the reverse split to allow the company to maintain its listing on the Nasdaq Capital Market.
Approval Process and Implementation
The specific ratio for the reverse stock split was determined and approved by the company's board of directors after discussions that commenced during earlier meetings. The chosen ratio of 1-for-30 was ratified on December 8, 2025, aligning the company's strategy with its operational goals. In conjunction with the split, the total authorized shares will decrease from 250 million to 25 million, reflecting a strategic realignment endorsed by stockholders.
Impact on Shareholders and Options
In a bid to balance the change, all shareholders will see the adjustments made to their shares. Importantly, the number of shares available under PAVmed's equity incentive and employee stock purchase plans will also be reduced proportionately to maintain the overall equity distribution. This adjustment extends to the company's outstanding stock options and convertible securities, ensuring that their exercise prices and shares remain consistent with the new structure.
Company's Future Vision
PAVmed Inc., known for its innovative approach, is set on a path that prioritizes advancements in medical solutions. With subsidiaries like Lucid Diagnostics Inc. (NASDAQ: LUCD), PAVmed continues to focus on mitigating serious health risks through technology. Lucid is pivotal in developing advanced diagnostics that facilitate early detection of esophageal cancer, showcasing PAVmed's dedication to improving patient outcomes through pioneering approaches.
Holistic Approach to Health Technology
Moreover, PAVmed's other subsidiary, Veris Health Inc., focuses on enhancing personalized cancer care through innovative monitoring solutions. By investing in remote patient monitoring technology, Veris Health aims to provide seamless medical care that changes how patients experience treatment. With a continuously evolving health landscape, PAVmed’s contributions are shaping the future of healthcare.
Contact Information and Resources
For those interested in exploring PAVmed's services and technologies, the company provides extensive resources on its website. Interested parties can find detailed information about PAVmed, Lucid Diagnostics, and Veris Health through their respective online platforms.
Frequently Asked Questions
What is a reverse stock split?
A reverse stock split reduces the number of a company's outstanding shares while increasing the share price proportionately, aimed at enhancing stock market performance and compliance with regulations.
Why did PAVmed decide to implement the reverse stock split?
The reverse stock split was introduced to meet Nasdaq's minimum bid price requirement, thereby securing its position on the exchange and enhancing shareholder value.
How will the stock split affect shareholders?
Shareholders will see their number of shares reduced according to the ratio; however, the overall value of their investment remains unaffected by this change.
What subsidiaries does PAVmed operate?
PAVmed operates several subsidiaries, including Lucid Diagnostics, which specializes in cancer diagnostics, and Veris Health, focusing on personalized cancer care technologies.
How can I find more information about PAVmed?
More information about PAVmed and its initiatives can be found on their official website, providing insights into their projects and advancements in the medical field.
